Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$457M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$258M |
| 3 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$220M |
| 4 |
SPDR Gold Trust
GLD
|
+$215M |
| 5 |
Intuit
INTU
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.63B |
| 2 |
Apple
AAPL
|
+$482M |
| 3 |
Microsoft
MSFT
|
+$437M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$394M |
| 5 |
Vanguard Total Bond Market
BND
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.52% |
| 2 | Healthcare | 10.14% |
| 3 | Consumer Discretionary | 8.2% |
| 4 | Industrials | 7.7% |
| 5 | Financials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.61M | ﹤0.01% |
468,686
-11,436
| -2% | -$49K |
|
|
ETJ
3377
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$573M
| $1.61M | ﹤0.01% |
168,251
-2,090
| -1% | -$20.8K |
|
|
RAPT
3378
DELISTED
RAPT Therapeutics
RAPT
| $1.61M | ﹤0.01% |
6,247
+948
| +18% | +$210K |
|
|
LUMO
3379
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.61M | ﹤0.01% |
116,392
+4,190
| +4% | +$62.6K |
|
3380
Scansource
SCSC
$1.1B
| $1.61M | ﹤0.01% |
80,977
+7,568
| +10% | +$172K |
|
|
SRDX
3381
DELISTED
Surmodics
SRDX
| $1.6M | ﹤0.01% |
41,238
+6,436
| +18% | +$283K |
|
3382
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$713M
| $1.6M | ﹤0.01% |
73,603
+3,450
| +5% | +$74.6K |
|
3383
The Joint Corp
JYNT
$122M
| $1.6M | ﹤0.01% |
92,144
-2,137
| -2% | -$34.9K |
|
3384
Kura Oncology
KURA
$874M
| $1.6M | ﹤0.01% |
52,136
-477
| -0.9% | -$10.5K |
|
|
XENT
3385
DELISTED
Intersect ENT, Inc
XENT
| $1.59M | ﹤0.01% |
97,755
-16,307
| -14% | -$295K |
|
3386
CALL
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.4B
| $1.59M | ﹤0.01% |
80,000
-196,400
| -71% | -$53.7M |
|
3387
PUT
ExxonMobil
XOM
$657B
| $1.59M | ﹤0.01% |
223,296
+200,265
| +870% | +$8.19M |
|
|
TBI
3388
Trueblue
TBI
$323M
| $1.59M | ﹤0.01% |
102,502
-5,316
| -5% | -$82K |
|
|
DCF
3389
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
| $1.59M | ﹤0.01% |
197,281
-8,947
| -4% | -$71.9K |
|
3390
Kinross Gold
KGC
$32.5B
| $1.58M | ﹤0.01% |
179,725
+53,331
| +42% | +$461K |
|
3391
The Bancorp
TBBK
$2.81B
| $1.58M | ﹤0.01% |
183,265
-43,399
| -19% | -$399K |
|
|
PFC
3392
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.58M | ﹤0.01% |
101,634
-48,384
| -32% | -$846K |
|
3393
Axogen
AXGN
$2.59B
| $1.58M | ﹤0.01% |
135,860
-41,983
| -24% | -$488K |
|
|
ADRE
3394
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
| $1.58M | ﹤0.01% |
33,840
+8,674
| +34% | +$395K |
|
|
AUY
3395
DELISTED
Yamana Gold, Inc.
AUY
| $1.58M | ﹤0.01% |
278,042
+25,271
| +10% | +$151K |
|
3396
iShares US Oil & Gas Exploration & Production ETF
IEO
$573M
| $1.56M | ﹤0.01% |
59,209
-238,567
| -80% | -$7.54M |
|
3397
Quanterix
QTRX
$114M
| $1.56M | ﹤0.01% |
46,352
+3,195
| +7% | +$103K |
|
3398
Costamare
CMRE
$1.74B
| $1.56M | ﹤0.01% |
257,250
+9,223
| +4% | +$47.2K |
|
3399
Dillards
DDS
$9.9B
| $1.55M | ﹤0.01% |
42,531
+12,560
| +42% | +$353K |
|
3400
Eastern Company
EML
$149M
| $1.55M | ﹤0.01% |
79,521
-304
| -0.4% | -$5.87K |
|
Similar funds
Wells Fargo's Q3 2020 Portfolio in Review
As of Q3 2020, Wells Fargo held 7,404 positions worth $362B, up 5.3% from $344B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wells Fargo's Q3 2020 filing shows 403 new, 2,558 increased, 3,361 reduced and 328 closed positions. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 9,801,595 shares worth $222M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.63B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Wells Fargo's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 9,801,595 shares worth $222M.
- Wells Fargo added most to Xtrackers USD High Yield Corporate Bond ETF in Q3 2020, an estimated $457M increase.
- Wells Fargo's biggest Q3 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.63B.
- Wells Fargo fully exited IBERIABANK Corp in Q3 2020, selling an estimated $24.1M.
- Wells Fargo's ten largest holdings make up 16% of its $362B portfolio in Q3 2020.
- Wells Fargo opened 403 new positions and closed 328 in Q3 2020.
- Wells Fargo's portfolio value rose 5.3% quarter-over-quarter to $362B.
Based on Wells Fargo's 13F filing for Q3 2020, filed 5 Nov 2020.